BRD4 facilitates glioma stem cell (GSC) properties through VEGF/PI3K/AKT signaling, and small molecule inhibitor JQ1 significantly inhibited the self-renewal of GSCs [201]. This evidence concerns the gene BRD4 and central nervous system cancer.